All News

Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment

August 01, 2021

The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.

FDA Updates: An Interchangeable Biosimilar for Insulin Leads the Week

July 31, 2021

Approval of the first interchangeable biosimilar; new indications for Keytruda, Botox, and Nucala; Shingrix label's expanded to a new patient population; and Ardelyx’s Complete Response Letter round out this week's FDA news.

The Importance of Reinsurance, Per Adam Gottesman of HM Insurance Group

July 30, 2021

In this special episode of Tuning In to the C-Suite podcast, MHE Associate Editor Briana Contreras met with HM Insurance Group Sales Director Adam Gottesman to discuss the ongoing and critical need for reinsurance in healthcare.